XRME:F:F-Xtrackers MSCI USA ESG Screened UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 8.945

Change

+0.15 (+1.68)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.21 (-0.77%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.56 (-1.08%)

USD 115.04B
FRCJ:F UBS MSCI Japan Socially Respon..

-0.21 (-0.97%)

USD 83.57B
SXR8:F iShares Core S&P 500 UCITS ETF..

+4.46 (+0.89%)

USD 80.45B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.36 (-0.65%)

USD 76.57B
EUNL:F iShares Core MSCI World UCITS ..

+0.38 (+0.42%)

USD 72.04B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.85 (-0.36%)

USD 58.19B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.11 (-0.69%)

USD 56.18B
VUSA:F Vanguard Funds Public Limited ..

+0.46 (+0.50%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.73 (+0.81%)

USD 49.95B

ETFs Containing XRME:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.66% 58% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.66% 56% F 57% F
Trailing 12 Months  
Capital Gain 24.13% 82% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.13% 81% B- 70% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 7.72% 76% C+ 72% C
Dividend Return 7.72% 74% C 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 10.96% 56% F 79% B-
Risk Adjusted Return 70.44% 91% A- 91% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike